Navigation Links
Ad hoc: Interim report about clinical trial of BF-200 ALA in,actinic keratosis

LEVERKUSEN, Germany, 30 April 2007 - Biofrontera AG announced that an interim report regarding the clinical study of BF-200 ALA in actinic keratosis was received today from an independent review committee. The objectives of the study are to investigate the efficacy and safety of several doses of BF-200 ALA in photodynamic therapy. The comments received today refer to the clinical results eight weeks after treatment. An additional report about the results after twelve weeks will follow.

The interim committee reported that no side effect justifying concerns about the safety of this dose were observed in any dose group. On the basis of the available data, the therapy was found to be safe for all doses tested.

In spite of the limited patient number, different doses gave rise to clear differences in efficacy. However, the results of the different doses were not yet disclosed. The committee announced this disclosure once it has received and analyzed the clinical results 12 weeks after treatment. Biofrontera expects this second report within few weeks.

To optimize the statistical study design, the committee has proposed to continue the phase III part of the study separately. This will enable the complete analysis of the 12-week data. On this basis, Biofrontera intends to continue the further development of the 10 % dose, provided this dose selection is supported by the 12-week data.

Biofrontera AG Hemmelrather Weg 201, 51377 Leverkusen, Germany ISIN: DE0006046113 WKN: 604611

Contact: Anke zur Mühlen Biofrontera AG Tel.: +49 (0214) 87 63 222 Fax.: +49 (0214) 87 63 290 e-mail: a.zurmuehlen@biofrontera.com


'"/>




Page: 1

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
3. Ablynx Announces Interim Results of First Nanobody Phase I Study of ALX-0081 (ANTI-VWF)
4. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
5. ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data Presented at International Myeloma Workshop
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Pharmacyclics Announces Interim Results From Two Ongoing Phase 2 Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat Recurrent Non-Small Cell Lung Cancer
8. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
9. Avalon Pharmaceuticals Announces Positive Interim Results For AVN944 Phase I Trial
10. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
11. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: hoc Interim report about clinical trial ALA actinic keratosis
(Date:9/17/2014)... , Sept. 17, 2014 Germany Gynecological ... GlobalData,s new report, "Germany Gynecological Devices Market ... the Germany Gynecological Devices market. The report provides ... units) and average prices (in US dollars) within ... Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips ...
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 ... of PDL BioPharma, Inc. ("PDL BioPharma" or the "Company") ... Robert S. Willoughby at rswilloughby@pomlaw.com or ... PDL BioPharma and certain of its officers and/or directors ... Exchange Act of 1934.  On September ...
(Date:9/17/2014)... 17, 2014 Bronstein, Gewirtz & Grossman, LLC ... the securities of PDL BioPharma, Inc. ("PDL BioPharma" or ... investors are advised to contact Peretz Bronstein ... at info@bgandg.com or 212-697-6484. The ... its executives violated federal securities laws. On ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Investigates claims on behalf of Investors of PDL BioPharma, Inc. --PDLI 2
(Date:9/18/2014)... September 18, 2014 For many people, tomato ... an online food delivery service provider, gives it a new ... Tomato Basil soup is a nod to this culinary classic—with ... a tangy tomato base, then Spoonful of Comfort's chefs stir ... A flashback to childhood has never tasted better. , ...
(Date:9/18/2014)... Computer Resources of America, Inc. (CRA), ... York City, has been awarded a contract to provide ... with stores in over 150 countries. The services will ... being the retailer’s dispatch arm handling all IT support ... Chief Executive Officer of CRA said, “We are excited ...
(Date:9/18/2014)... Albany, NY (PRWEB) September 18, 2014 ... foods, which have special functions of adjusting human ... etc., have won great popularity with a variety ... of health food in China reached RMB187.4 billion, ... of 22.1% during 2006-2013. , View Full Report ...
(Date:9/18/2014)... Boston, MA (PRWEB) September 18, 2014 ... train its team and surgeon partners in Less ... to joining SpineFrontier, Tamara authored an extensive education ... holds a Masters in Science in Organizational Leadership, ... multiple industries for eleven years. Bringing her to ...
(Date:9/18/2014)... September 18, 2014 Dr. Suzaunna Clark, ... 1- sometimes, inner beauty has to be seen to ... be acknowledged in order to be used. Together, both ... shows the world how to do both. ... Coaching using the Healing Hearts system, which provides professional ...
Breaking Medicine News(10 mins):Health News:An Old Classic Brings New Soup Delivery Options to Spoonful of Comfort 2Health News:CRA Awarded Managed Support Contract for Global Retailer 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 2Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 3Health News:China Health Food Industry Size 2014 Market Analysis, Growth, Trends and Forecast Report 2017: MarketResearchReports.biz 4Health News:SpineFrontier Inc. Makes Bold Move to Expand Its Internal Training Team to Collaborate With The LESSociety’s Less Exposure Surgery® University To Educate Surgeons. 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 2Health News:Suzaunna-Where Life! Happens Announces the Launch of Healing Hearts 3
... seek answers to questions of motivation and self-actualization. "Make ... Honaman employs lessons learned in his career working with ... to help others direct their energies and develop their ... "Make It Happen" that personal branding is the process ...
... 20 Hooper Holmes, Inc. (Amex: HH ... Health and Wellness Division, Christopher J. Behling, will be ... Colloquium on Tuesday, March 3, 2009 at 9:00 a.m. ... Regency at Penn,s Landing in Philadelphia, Pennsylvania. Mr. Behling,s ...
... Faced with news of increasing layoffs, straining economic times, ... hiring is based on looks, millions of American women ... them a competitive edge in the workplace. In a ... of 18 and 64 compiled by the ASPS, many ...
... 20 The Niwano Peace Foundation announced Friday it will ... Baguma Byamugisha, an Anglican priest of Uganda, in recognition of ... people living with HIV/AIDS.An award presentation ceremony will take place ... award certificate, Rev. Byamugisha will receive a medal and 20 ...
... York, NY, February 20, 2009 Although widespread Prostate-Specific-Antigen ... there a point of diminishing returns? In a study ... Journal of Urology , researchers found that in a ... years old or older and had a PSA below ...
... in chronic obstructive lung disease (COPD) themselves increase ... days of full, asymptomatic recoverybad news for patients ... progression of the disease. , "This concept ... for the analysis of clinical trial data and ...
Cached Medicine News:Health News:Business Strategist Applies Corporate Experience to Self-Help: 'Make It Happen' 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 2Health News:Hooper Holmes to Present at the Ninth Population Health and Disease Management Colloquium 3Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 2Health News:In Today's Economy, Women In The Workforce Link Cosmetic Chicago Plastic Surgery To Success 3Health News:Rev. Byamugisha of Uganda to Receive Niwano Peace Prize 2Health News:When should prostate-specific antigen testing be stopped? 2Health News:Exacerbations in COPD: One thing leads to another 2Health News:Exacerbations in COPD: One thing leads to another 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: